A blood test prescription remains valid for a maximum duration of twelve months from the date of issuance. This period, often confused with that of medication prescriptions (three months for the first dispensing), leads to avoidable refusals at the laboratory. Understanding the mechanisms of validity, renewal, and recent developments helps avoid unnecessary consultations and breaks in biological monitoring.
Nursing samples and expired prescriptions: what the 2025 decree changes
A liberal nurse can now continue blood sampling as part of chronic disease monitoring, even when the validity date of the initial prescription has passed. This 2025 decree, still little known in public content, concretely changes practice for patients with long-term illnesses, insulin-dependent diabetics, or renal insufficiency patients followed in the community.
The framework remains strict. The initial prescription must explicitly include the sampling acts. Continuity applies to monitoring situations (quarterly HbA1c, creatinine, INR), not to exploratory or diagnostic assessments. The nurse does not renew the prescription; they extend the execution of an already prescribed act.
In practice, we observe that this measure reduces breaks in monitoring for patients struggling to get a medical appointment in time. The laboratory retains the right to refuse a sample if the prescription does not mention chronic monitoring or if the clinical context has clearly changed.
The question of reusing a prescription for a blood test thus arises differently depending on whether the patient is under structured chronic monitoring or a classic one-time prescription.
Blood test prescription: validity period and reuse conditions
The twelve-month period starts from the date written on the prescription, not from the first use. A prescription dated January 15 expires on January 14 of the following year, regardless of whether the first sample was taken in February or September.
Reuse entirely depends on the wording of the prescribing physician. Two mentions change everything:
- The mention “to be renewed” followed by a frequency (every three months, every six months) allows multiple visits to the laboratory during the validity period, without a new consultation.
- The absence of a renewal mention limits the prescription to one visit to the laboratory for all the listed analyses.
- A mention “checkup in three months” counts as a single renewal request, not unlimited quarterly renewals over twelve months.
We recommend checking the exact wording before leaving the office. An “to be renewed x 3” is unambiguous. An isolated “to be rechecked” leaves room for interpretation that the laboratory will often rule against.
Laboratory refusal on old prescriptions
A laboratory can refuse a technically valid prescription (less than twelve months) if the medical context has changed. The argument is based on clinical relevance: a TSH prescribed eleven months ago after an acute episode may no longer correspond to the patient’s current situation.
Reimbursement by Health Insurance is another frequent reason for refusal. A prescription nearing its limit exposes the laboratory to billing rejection by the CPAM, which explains the caution of some biologists beyond six months.
Nurses’ autonomous prescribing: impact on routine biology analyses
Starting in 2026, advanced practice nurses and certain state-certified nurses will have autonomous prescribing rights for routine biology acts. This evolution, stemming from the Rist law and its implementing decrees, directly concerns the most common monitoring analyses.
The scope is not yet fully stabilized, but the preparatory texts target routine assessments: blood glucose, lipid profile, complete blood count, creatinine. The prescription will no longer necessarily come from a doctor for these acts, which will change the prescription-execution chain in areas underserved by general practitioners.
In practice, a patient being monitored for type 2 diabetes could obtain their HbA1c prescription directly from their referring nurse, without going through the treating physician. The validity of this nursing prescription will follow the same rules as classic medical prescriptions.
Digital prescriptions and traceability of blood tests
E-prescription, currently being deployed via the SESAM-Vitale system, adds a layer of control that makes the question of reuse more transparent. Each digital prescription carries a unique identifier recorded in a national database. The laboratory can instantly verify if the prescription has already been executed, how many times, and if a renewal is planned.
This system effectively eliminates gray areas. With a paper prescription, a patient could present the same document at two different laboratories. The digital prescription makes this double use technically impossible.
For prescriptions to be renewed, e-prescription automatically manages the calendar. The laboratory sees the number of remaining visits and the expected dates. In case of exceeding the twelve-month period, the system blocks coverage.
What this changes for the patient
The transition to dematerialized prescriptions does not change legal deadlines. It reduces disputes related to “multiple-use” prescriptions and clarifies the right to renewal. However, it requires having an up-to-date Vitale card and access to the online service to consult active prescriptions.
Patients who kept a photocopy of a paper prescription for their recurring samples will need to adapt their habits. The laboratory will no longer be able to accept a copy without verification in the national database, which strengthens the reliability of the process but reduces the informal flexibility that existed until now.